Ventyx Biosciences is a biotechnology business based in the US. Ventyx Biosciences shares (VTYX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.78 – a decrease of 11.88% over the previous week. Ventyx Biosciences employs 75 staff and has a market cap (total outstanding shares value) of 0.00.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.78 |
|---|---|
| 52-week range | $1.79 - $11.48 |
| 50-day moving average | $2.24 |
| 200-day moving average | $3.57 |
| Wall St. target price | $10.50 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-2.35 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.77 from 2024-11-18
| 1 week (2024-11-13) | -12.38% |
|---|---|
| 1 month (2024-10-18) | -30.31% |
| 3 months (2024-08-20) | -9.69% |
| 6 months (2024-05-20) | -63.35% |
| 1 year (2023-11-20) | -25.00% |
|---|---|
| 2 years (2022-11-18) | -93.26% |
| 3 years (2021-11-19) | 21.9 |
| 5 years (2019-11-17) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -33.39% |
| Return on equity TTM | -54.24% |
| Profit margin | 0% |
| Book value | $3.95 |
| Market Capitalization | $139.3 million |
TTM: trailing 12 months
We're not expecting Ventyx Biosciences to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Ventyx Biosciences's shares have ranged in value from as little as $1.79 up to $11.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ventyx Biosciences's is 0.366. This would suggest that Ventyx Biosciences's shares are less volatile than average (for this exchange).
To put Ventyx Biosciences's beta into context you can compare it against those of similar companies.
Ventyx Biosciences, Inc. , a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.